Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 2, 2026

FIM Imaging and FIMtrack: Two New Tools Allowing High-throughput and Cost Effective Locomotion Analysis
10:02

FIM Imaging and FIMtrack: Two New Tools Allowing High-throughput and Cost Effective Locomotion Analysis

Published on: December 24, 2014

13.7K

Fabian Müller.

Fabian Müller

    Med (New York, N.Y.)
    |June 15, 2024
    PubMed
    Summary
    This summary is machine-generated.

    Chimeric antigen receptor T cell (CAR T) therapy shows promise for treating autoimmune diseases. Further research is exploring its future applications in this field.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Zongertinib in Healthy Male Volunteers.

    Pharmacotherapy·2026
    Same author

    Outcomes of CAR-T Cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.

    Blood cancer discovery·2026
    Same author

    Prognostic role of FDG-PET in patients with relapsed/refractory large B-cell lymphoma treated with CD3-CD20 directed bispecific antibodies: a multicentric analysis.

    European journal of nuclear medicine and molecular imaging·2026
    Same author

    Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells.

    Nature communications·2026
    Same author

    Standard-of-care ciltacabtagene autoleucel in earlier versus later lines of therapy for relapsed or refractory multiple myeloma: a nationwide registry analysis.

    Journal of hematology & oncology·2026
    Same author

    Universal high-sensitivity CAR T-cell monitoring by targeting linker sequences.

    Frontiers in immunology·2026
    Same journal

    AI-driven therapeutic antisense oligonucleotide for processing-deficient progeroid laminopathies.

    Med (New York, N.Y.)·2026
    Same journal

    Advanced cholangiocarcinoma in 2025: Therapeutic sequencing and global implementation.

    Med (New York, N.Y.)·2026
    Same journal

    Atlas of human brain imaging-derived phenotypes and disease risk.

    Med (New York, N.Y.)·2026
    Same journal

    Withdrawal effects following treatment discontinuation: A blind spot in evidence-based medicine.

    Med (New York, N.Y.)·2026
    Same journal

    Rethinking parenteral nutrition as supportive therapy for neonatal sepsis.

    Med (New York, N.Y.)·2026
    Same journal

    Power and sample-size estimation in human microbiome research.

    Med (New York, N.Y.)·2026
    See all related articles

    Area of Science:

    • Immunotherapy
    • Hematology
    • Autoimmune Diseases

    Background:

    • CAR T cell therapy has revolutionized cancer treatment.
    • Its potential application in autoimmune diseases is an emerging area of research.

    Purpose of the Study:

    • To discuss the future of CAR T cell therapy for autoimmune diseases.
    • To explore the potential benefits and challenges of this therapeutic approach.

    Main Methods:

    • Expert discussion and review of current research.
    • Analysis of the immunological mechanisms involved.

    Main Results:

    • CAR T cell therapy holds significant potential for treating various autoimmune conditions.
    • Challenges include ensuring target specificity and managing potential side effects.

    More Related Videos

    Fused Filament Fabrication FFF of Metal-Ceramic Components
    08:43

    Fused Filament Fabrication FFF of Metal-Ceramic Components

    Published on: January 11, 2019

    18.9K
    Ultrasonic-augmented Primary Adult Fibroblast Isolation
    06:51

    Ultrasonic-augmented Primary Adult Fibroblast Isolation

    Published on: July 29, 2019

    7.5K

    Related Experiment Videos

    Last Updated: May 2, 2026

    FIM Imaging and FIMtrack: Two New Tools Allowing High-throughput and Cost Effective Locomotion Analysis
    10:02

    FIM Imaging and FIMtrack: Two New Tools Allowing High-throughput and Cost Effective Locomotion Analysis

    Published on: December 24, 2014

    13.7K
    Fused Filament Fabrication FFF of Metal-Ceramic Components
    08:43

    Fused Filament Fabrication FFF of Metal-Ceramic Components

    Published on: January 11, 2019

    18.9K
    Ultrasonic-augmented Primary Adult Fibroblast Isolation
    06:51

    Ultrasonic-augmented Primary Adult Fibroblast Isolation

    Published on: July 29, 2019

    7.5K

    Conclusions:

    • CAR T cell therapy represents a promising frontier in autoimmune disease treatment.
    • Continued investigation is crucial to optimize its safety and efficacy.